Thursday | 8 January, 2009
Biotech briefs
Molloy joins Viralytics
Former Biota CEO Peter Molloy has been appointed a non-executive director of Sydney biotech Viralytics (ASX: VLA).
Viralytics is in Phase 1 trials of an oncolytic virus technology called Cavatak in late-stage metastatic melanoma patients and another in prostate cancer.
Molloy is now a US-based industry consultant.
More About: Viralytics
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Fujitsu Introduces First Netbook Series – Fujitsu M1010, the Comprehensive Solution for Work and Play. 2008-12-15 16:30:00+11
Kingston Technology Boosts DataTraveler 150 Capacity to 64GB 2008-12-09 15:30:00+11
IDC Says Asia/Pacific Excluding Japan IT Market Will Remain The Bright Spot... 2008-12-04 15:04:00+11
AOC Launches 18.5” Widescreen Green 16:9 LCD Monitor in Australia and New Zealand 2008-12-03 15:30:00+11
NComputing Appoints Country Manager for Australia, New Zealand, and South Pacific Islands 2008-12-03 00:43:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
